BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11160678)

  • 1. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
    Jeong J; Papin J; Dittmer D
    J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
    Staudt MR; Dittmer DP
    Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
    Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
    J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
    Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
    J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
    Verma SC; Lan K; Choudhuri T; Robertson ES
    J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
    Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
    J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
    Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
    J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
    Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
    J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
    Dittmer DP
    Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
    Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
    J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Jeong JH; Orvis J; Kim JW; McMurtrey CP; Renne R; Dittmer DP
    J Biol Chem; 2004 Apr; 279(16):16822-31. PubMed ID: 14742422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.